Influenza tetravalent vaccine (Cadila Healthcare)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInfluenza tetravalent vaccine (Cadila Healthcare)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A
Develop Information
Active CompaniesZydus Lifesciences Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A